We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
IT has an impressive earnings surprise history. In the four trailing quarters, it surpassed the Zacks Consensus Estimate, with an average surprise of 10.3%.
The Zacks Consensus Estimate for the top line is pinned at $1.5 billion, implying a marginal dip from the year-ago quarter’s actual.
The consensus estimate for the Insights segment’s revenues is set at $1.3 billion, suggesting a 2.9% year-over-year dip. The consensus estimate for Conferences’ revenues is kept at $75 million, hinting at a 2.7% rise from that reported in the same quarter last year. For Consulting, the Zacks Consensus Estimate for revenues is set at $139 million, suggesting a marginal dip from the prior-year quarter’s actual.
For gross contribution, the consensus estimate for Insights is kept at $1 billion, indicating 1.9% growth from the year-ago quarter’s actual. For conferences, the Zacks Consensus Estimate is pegged at $29 million, suggesting a 7.4% year-over-year increase. The consensus mark for consulting is at $51 million, implying a 3.8% decline from the year-ago quarter’s actual.
The consensus estimate for earnings per share is $2.99, suggesting slight growth from the year-ago quarter.
What Our Model Says About IT
Our proven model does not conclusively predict an earnings beat for Gartner this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
IT has an Earnings ESP of 0.00% and a Zacks Rank of 4 (Sell) at present.
Stocks to Consider
Here are a few stocks, according to our model, that have the right combination of elements to beat on earnings this season.
Coherent Corp. (COHR - Free Report) : The Zacks Consensus Estimate for third-quarter 2026 revenues is pegged at $1.8 billion, hinting at an 18.8% jump from the year-ago quarter’s actual. For earnings, the consensus mark is pegged at $1.41 per share, a 55% year-over-year rally from the year-ago quarter. COHR missed the consensus estimate in the trailing four quarters, with an average surprise of 7.7%.
It is scheduled to declare first-quarter 2026 results on May 6.
BridgeBio Pharma (BBIO - Free Report) : The Zacks Consensus Estimate for the company’s first-quarter 2026 revenues is pinned at $179.8 million, suggesting growth of 54.2% from the year-ago quarter’s actual. For loss, the consensus mark is set at 70 cents per share compared with a loss of 88 cents in the year-ago quarter. BBIO beat the consensus estimate for earnings in one of the four quarters and missed thrice, with an average negative surprise of 10.9%.
BBIO has an Earnings ESP of +1.28% and a Zacks Rank of 3 at present. The company is scheduled to declare first-quarter 2026 results on May 7.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Gartner Gears Up to Report Q1 Earnings: What's in the Offing?
Key Takeaways
Gartner Inc. (IT - Free Report) will release first-quarter 2026 results on May 5, before market open.
IT has an impressive earnings surprise history. In the four trailing quarters, it surpassed the Zacks Consensus Estimate, with an average surprise of 10.3%.
Gartner, Inc. Price and EPS Surprise
Gartner, Inc. price-eps-surprise | Gartner, Inc. Quote
Gartner’s Q1 Expectations
The Zacks Consensus Estimate for the top line is pinned at $1.5 billion, implying a marginal dip from the year-ago quarter’s actual.
The consensus estimate for the Insights segment’s revenues is set at $1.3 billion, suggesting a 2.9% year-over-year dip. The consensus estimate for Conferences’ revenues is kept at $75 million, hinting at a 2.7% rise from that reported in the same quarter last year. For Consulting, the Zacks Consensus Estimate for revenues is set at $139 million, suggesting a marginal dip from the prior-year quarter’s actual.
For gross contribution, the consensus estimate for Insights is kept at $1 billion, indicating 1.9% growth from the year-ago quarter’s actual. For conferences, the Zacks Consensus Estimate is pegged at $29 million, suggesting a 7.4% year-over-year increase. The consensus mark for consulting is at $51 million, implying a 3.8% decline from the year-ago quarter’s actual.
The consensus estimate for earnings per share is $2.99, suggesting slight growth from the year-ago quarter.
What Our Model Says About IT
Our proven model does not conclusively predict an earnings beat for Gartner this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
IT has an Earnings ESP of 0.00% and a Zacks Rank of 4 (Sell) at present.
Stocks to Consider
Here are a few stocks, according to our model, that have the right combination of elements to beat on earnings this season.
Coherent Corp. (COHR - Free Report) : The Zacks Consensus Estimate for third-quarter 2026 revenues is pegged at $1.8 billion, hinting at an 18.8% jump from the year-ago quarter’s actual. For earnings, the consensus mark is pegged at $1.41 per share, a 55% year-over-year rally from the year-ago quarter. COHR missed the consensus estimate in the trailing four quarters, with an average surprise of 7.7%.
COHR has an Earnings ESP of +3.08% and a Zacks Rank of 2 at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
It is scheduled to declare first-quarter 2026 results on May 6.
BridgeBio Pharma (BBIO - Free Report) : The Zacks Consensus Estimate for the company’s first-quarter 2026 revenues is pinned at $179.8 million, suggesting growth of 54.2% from the year-ago quarter’s actual. For loss, the consensus mark is set at 70 cents per share compared with a loss of 88 cents in the year-ago quarter. BBIO beat the consensus estimate for earnings in one of the four quarters and missed thrice, with an average negative surprise of 10.9%.
BBIO has an Earnings ESP of +1.28% and a Zacks Rank of 3 at present. The company is scheduled to declare first-quarter 2026 results on May 7.